東京女子医科大学雑誌
Online ISSN : 2432-6178
Print ISSN : 0040-9022
ISSN-L : 0040-9022
特集 COVID-19
薬剤開発・薬物治療
塚原 富士子丸 義朗
著者情報
ジャーナル オープンアクセス

2021 年 91 巻 1 号 p. 19-28

詳細
抄録

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in late 2019. It has been rapidly spreading worldwide ever since. The majority of COVID-19 infections are asymptomatic or mildly symptomatic. However, old age or comorbidities can result in a cytokine storm, which eventually leads to death. To date, no drug has been clinically proven effective to treat COVID-19, and development of effective drugs against SARS-CoV-2 is urgently required. Several drugs used in treating other diseases are being evaluated. Clinical trials on many new antiviral drugs and vaccine candidates are also rapidly ongoing. In this review, we summarized the currently used drugs and newly developed vaccines for the treatment of COVID-19.

著者関連情報
© 2021 東京女子医科大学学会

この記事はクリエイティブ・コモンズ [表示 4.0 国際]ライセンスの下に提供されています。 This article is licensed under a Creative Commons [Attribution 4.0 International] license.
https://creativecommons.org/licenses/by/4.0/deed.ja
前の記事 次の記事
feedback
Top